Emotra’s management team has just returned from several days of hard work and successes in connection with the EPA’s conference in Florence, Italy. Researchers from a number of countries have reached out to congratulate us on our successfully concluded study and to register their interest in learning more about EDOR®. Professor Marco Sarchiapone presented our preliminary analysis of the study results. This analysis was completed with a short deadline after our study was closed on March 10. He concluded that EDOR® is the first ever objective tool for identifying a biomarker for suicide risk and that the method now opens the door for more systematic methods of evaluating suicide risk in psychiatric care.